A new report from the Alliance of Regenerative Medicine shows what a record year the sector had in 2017 with a 78.5 percent year-over-year funding increase to more than $7.5 billion.
Gilead has been looking for ways to add to its portfolio beyond infectious-disease treatments especially in light of the company's declining hepatitis C drugs sales, The Wall Street Journal observed.
Explore top PTSD treatment centers in Arizona, offering personalized care, holistic therapies and expert support to help individuals heal and reclaim their lives.